18 Nov How decentralisation can fill the gaps in Alzheimer’s research
Alzheimer’s trials face the unique challenge of studying participants with cognitive decline, amid a move towards digital technologies....
Alzheimer’s trials face the unique challenge of studying participants with cognitive decline, amid a move towards digital technologies....
Today marks the final phase of new patient appointments at Eastpark....
Mass General Brigham, Emory and other providers, including the UW–Madison School of Medicine and Public Health, will assess different AI models from companies like Google, Microsoft and Amazon....
At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and discern ways to overcome sector challenges....
Women across the country are searching for answers to improve their health. They’re trying to manage flare-ups from autoimmune diseases. They’re dealing with chronic pain. They’re coping with postpartum depression. For these experiences and more, we still have much work to do....
To help protect patients and care teams from illness, UW Health will begin annual masking requirements starting in mid-November and ending in mid-March to align with the usual respiratory virus season....
As trials become more patient-centric, understanding the diverse perspectives and needs of participants has never been more critical....
Meet the Wisconsin nurse who’s helping patients and their families make informed decisions about clinical trials....
Most people think of skin cancer when they hear melanoma, but there is a rare subtype that can also develop in the eye called uveal melanoma....
The National Comprehensive Cancer Network (NCCN) hosted a policy summit at the National Press Club in Washington, DC, to highlight the need for more diversity, equity, and inclusion (DEI) in the cancer care workforce....